HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 275, Issue 32, 25008-25014, August 11, 2000

This Article Abstract Full Text (PDF) All Versions of this Article: 275/32/25008    most recent M002491200v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zhang, Y. Articles by Lin, S.-C. Search for Related Content PubMed PubMed Citation Articles by Zhang, Y. Articles by Lin, S.-C. Social Bookmarking                      What's this?

Dimerization Choices Control the Ability of Axin and Dishevelled to Activate c-Jun N-terminal Kinase/Stress-activated Protein Kinase^*

Yi Zhang, Soek Ying Neo, Jiahuai Han^§, and Sheng-Cai Lin^¶

From the Regulatory Biology Laboratory, Institute of Molecular and Cell Biology, National University of Singapore, 30 Medical Drive, Singapore 117609, Republic of Singapore and the ^§ Department of Immunology, The Scripps Research Institute, La Jolla, California 92037

Received for publication, March 24, 2000, and in revised form, May 23, 2000

	ABSTRACT

TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES

Axin and Dishevelled are two downstream components of the Wnt signaling pathway. Dishevelled is a positive regulator and is placed genetically between Frizzled and glycogen synthase kinase-3, whereas Axin is a negative regulator that acts downstream of glycogen synthase kinase-3. It is intriguing that they each can activate the c-Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) when expressed in the cell. We set out to address if Axin and Dishevelled are functionally cooperative, antagonistic, or entirely independent, in terms of the JNK activation event. We found that in contrast to Axin, Dvl2 activation of JNK does not require MEKK1, and complex formation between Dvl2 and Axin is independent of Axin-MEKK1 binding. Furthermore, Dvl2-DIX and Dvl2-DEP proteins deficient for JNK activation can attenuate Axin-activated JNK activity by disrupting Axin dimerization. However, Axin-MID, Axin-C, and Axin-CT proteins deficient for JNK activation cannot interfere with Dvl2-activated JNK activity. These results indicate that unlike the strict requirement of homodimerization for Axin function, Dvl2 can activate JNK either as a monomer or homodimer/heterodimer. We suggest that there may be a switch mechanism based on dimerization combinations, that commands cells to activate Wnt signaling or JNK activation, and to turn on specific activators of JNK in response to various environmental cues.

	INTRODUCTION

TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES

Axin and Dishevelled are two of the key components of the Wnt signaling pathway, a highly conserved developmental pathway in eukaryotic cells that controls cell fate determination (reviewed in Refs. 1-4). Genetic studies have shown that Axin is a negative regulator of Wnt signaling in that its mutation results in axis duplication (5, 6). In the absence of a Wnt signal, Axin serves as a scaffold upon which adenomatous polyposis coli (APC),¹ glycogen synthase-3 (GSK-3), and -catenin assemble (6-10). This complex formation enhances the phosphorylation of -catenin by GSK-3, leading to the degradation of -catenin. Activation of the Wnt signaling pathway via ligand binding to Frizzled receptors stimulates Dishevelled to inhibit GSK-3, thus impairing its ability to downregulate -catenin. The accumulated -catenin is then translocated into the nucleus where it associates with the lymphoid enhancer factor or T-cell factor transcription factors (11, 12) to regulate expression of genes such as the c-myc oncogene (13). The structural requirements of both Dishevelled and Axin for Wnt signaling have been defined. Axin possesses a regulator of G protein signaling homologous domain for APC binding, a GSK-3 binding site, a -catenin binding domain, and a Dishevelled homologous (DIX) domain (6-9, 14), all of which are necessary for Wnt signaling, although the importance of the DIX domain is still unclear. The Dishevelled protein consists of three conserved domains: an N-terminal DIX domain, a central PDZ domain conserved in presynaptic density protein-95, Drosophila tumor suppressor Dlg, and ZO-1, and a C-terminal DEP domain shared by Dishevelled, egl-10, and pleckstrin (3, 4, 15-17). Both the DIX and PDZ domains are absolutely essential for Wnt signaling, whereas the DEP domain is dispensable (18). However, the precise mechanism of action of Dishevelled is as yet unknown.

In addition to Wnt signaling, Dishevelled is also known to function in the generation of epithelial planar polarity in Drosophila (15, 19, 20). Genetic and molecular assays have revealed that the DEP domain of Dishevelled is required for planar cell polarity signaling by activating the c-Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) cascade (15, 20) and Rho is involved in this pathway (21). As with Dishevelled, Axin also appears to have a dual function. We have recently reported that apart from its well characterized role in Wnt signaling, Axin has a novel functional role that serves to activate JNK (22). Domains on Axin known to be required for Wnt signaling, i.e. the regulator of the G protein signaling homologous domain for APC binding and regions for binding GSK-3 and -catenin are not involved in this JNK activation. A novel domain, which we term MEKK1-interacting domain (MID), flanked by the APC- and GSK-3 binding sites and the C-terminal region of Axin, which includes the oligomerization domain, is essential for JNK activation.

It is intriguing that Axin and Dishevelled, which are negative and positive regulators, respectively, in the same Wnt signaling cascade, can both activate JNK when expressed in the cell. Genetic analyses have placed Dishevelled downstream of the Frizzled receptor and upstream of GSK-3, and Axin between GSK-3 and -catenin (4). Whether Axin and Dishevelled activate JNK through the same or different mechanisms is not clear. Whereas it has been shown that they both have dimerization domains and that they interact with each other through the DIX domain (23, 24), little is known if they are functionally cooperative, antagonistic, or entirely independent in JNK activation. Here, we report that MEKK1 is not involved in Dvl2-mediated JNK, unlike JNK activation by Axin. We examined a possible mutual regulation between the Axin- and Dvl2-mediated JNK signaling pathway, and demonstrate that whereas Dvl2-activated JNK activity is not affected by Axin, Axin-mediated JNK activation may be regulated by Dvl2 through the DIX domain. Dimerization is critical for Axin activation of JNK, whereas it appears to not be requisite for Dishevelled activation of JNK. Our data suggest that dimerization choices determine the ability of Axin and Dishevelled to activate JNK.

	MATERIALS AND METHODS

TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES

Construction of Plasmids-- A series of different constructs of mouse Dvl2 (Fig. 3A) were created using convenient restriction enzyme sites. Briefly, to construct mutants HA-Dvl2-DEP and HA-Dvl2-DIX, the N terminus of wild-type Dvl2 was deleted at the ApaLI and XbaI sites, respectively, and fused in-frame to the HA tag. To construct HA-Dvl2-PDZ, wild-type Dvl2 was digested internally at XhoI and ApaLI sites, blunted with Klenow fragment, and religated in-frame. To construct HA-Dvl2-DEP, the region between NotI and HpaI of wild-type Dvl2 was released and replaced with a polymerase chain reaction-generated fragment using the primers 5'-GGAAGCAGCGGCCGCCACGC-3' and 5'-gttaacGGCCATGTCCATGTGGAC-3'. Constructs for wild-type Axin, Axin-MID, Axin-C, and Axin-CT (Fig. 5A) have been previously described (22). Expression vectors for MEKK1, MEKK1-K1255M, and MEKK1-C were gifts from Dr. M. Karin (University of California, San Diego, CA), and HA-Dvl1 was kindly provided by Dr. A. Kikuchi (Hiroshima University School of Medicine, Hiroshima, Japan).

Transient Transfection and Immunokinase Assays-- Human embryonic kidney 293T cells were maintained in RPMI 1640 medium supplemented with 10% fetal bovine serum, 100 IU penicillin, 100 µg/ml streptomycin, and 2 mM glutamine. Transfections were performed in 60-mm dishes using Superfect^TM according to the manufacturer's instructions (Qiagen). The total amount of transfected DNA was adjusted to 4 µg with the empty vector pCMV5 where necessary. Cells were harvested at 40 h post-transfection and lysed in a lysis buffer (22). FLAG-tagged JNK1 was immunoprecipitated using mouse monoclonal anti-FLAG M2 beads (Sigma), and the kinase activities were determined as described previously using 1 µg of GST-c-Jun (amino acids 1-79; Stratagene) as substrate (22). Fold activation of the kinases was determined by an imaging analyzer (Molecular Dynamics model 425E) and normalized to their expression levels. Data are expressed as -fold kinase activation compared with vector-transfected cells, and the values represent the mean ± S.E. from three separate experiments.

Coimmunoprecipitation and Western Blot Analysis-- Transiently transfected 293T cells in 60-mm dishes were lysed in a lysis buffer (20 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton, 2.5 mM sodium pyrophosphate, 1 mM -glycerolphosphate, 1 mM sodium orthovanadate, 1 µg/ml leupeptin, 1 mM phenylmethylsulfonyl fluoride), sonicated three times for 5 s each, and centrifuged at 13,000 rpm for 30 min at 4 °C. HA-tagged or Myc-tagged proteins were immunoprecipitated from the cell lysate with anti-HA (Roche Molecular Biochemicals), anti-Myc (9E10), or anti-MEKK1 (C-22) (Santa Cruz Biotechnology, Inc.) antibodies and Protein A/G Plus-agarose beads (Santa Cruz Biotechnology, Inc.) as indicated. Immunoprecipitates or total cell lysates were analyzed by Western blotting as described previously (22). The boiled samples were separated on 10% SDS-polyacrylamide gels and transferred to Immobilon-P membranes (Millipore). After blocking with 5% nonfat milk in Tris-buffered saline with 0.1% Tween 20 for 1 h, the membranes were probed with anti-HA, anti-Myc (9E10), anti-MEKK1 (C-22), or anti-FLAG M2 (Sigma) antibodies. Bound antibodies were visualized by enhanced chemiluminescence (Amersham Pharmacia Biotech) using horseradish peroxidase-conjugated antibodies.

	RESULTS

TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES

Dvl2 Activation of JNK Does Not Require MEKK1 and Binding of Dvl2 to Axin Is Independent of the Axin-MEKK1 Interaction-- We have previously demonstrated that MEKK1 binds Axin and is critical for Axin activation of JNK (22). Because Dishevelled possesses the ability to activate JNK (25, 26), we asked whether MEKK1 played a role in JNK activation by Dvl2. 293T cells were separately cotransfected with Dvl2, FLAG-JNK1, and wild-type HA-MEKK1 or its kinase-inactive mutant HA-MEKK1-K1255M, and assayed for their abilities to activate JNK. Similar kinase assays were performed on cells cotransfected with Axin as control. As expected, Dvl2 and MEKK1 each activated JNK by about 4- and 8-fold, respectively (Fig. 1A). Coexpression of Dvl2 with MEKK1 further elevated JNK activity (~12-fold), but the kinase-inactive form of MEKK1, which reduced Axin activation of JNK (22), did not appear to alter Dvl2 activation of JNK (Fig. 1A). These results suggest that MEKK1 does not play a role in Dvl2-mediated activation of JNK. In agreement with our above observations, we did not detect any interaction between Dvl2 and full-length MEKK1 or the C terminus of MEKK1 (MEKK1-C) in coimmunoprecipitation assays (Fig. 1B). We also addressed whether the dominant negative forms of other upstream activators of JNK such as TAK1-K63W, ASK1-K709M, Cdc42N17, and RacN17 could block Dvl2-mediated JNK activation. We found that Dvl2-induced JNK activation was significantly suppressed by dominant negative Cdc42N17 and RacN17,² in agreement with a report on the involvement of Rac1 and Cdc42 in Dvl1-induced JNK activation (26). In contrast, we did not see any apparent change in Axin-mediated JNK activation in the presence of dominant negative Cdc42N17 and RacN17 (22), suggesting that the JNK pathways activated by Axin and Dvl2 are distinct.

View larger version (17K): [in this window] [in a new window]   Fig. 1.   Dvl2 activation of JNK is independent of MEKK1. A, kinase-inactive form of MEKK1 does not abolish Dvl2 activation of JNK. Cells were transiently transfected with 1 µg of FLAG-JNK1 plus 2 µg of either HA-MEKK1 or HA-MEKK1-K1255M in the presence (dark columns) or absence (light columns) of 1 µg of HA-Dvl2. Following immunoprecipitation of FLAG-JNK1, their kinase activities were assayed using GST-c-Jun as substrate. The amount of the kinase in each immunoprecipitate was quantified by immunoblotting. Data are expressed as -fold kinase activation compared with vector-transfected cells. The values represent the mean ± S.E. from three separate experiments. Total cell lysates were probed with anti-HA to detect the expression of HA-MEKK1 (lanes 3 and 4) and HA-MEKK1-K1255M (lanes 5 and 6) in the presence (lanes 4 and 6) or absence (lanes 3 and 5) of Dvl2. B, Dvl2 does not form a complex with MEKK1. Cells were transfected with 1.5 µg of HA-Dvl2 plus 1.5 µg of either Myc-MEKK1 or Myc-MEKK1-C, cell lysates were immunoprecipitated (IP) with anti-HA for Dvl2, anti-MEKK1 for MEKK1, or control IgG. The immunoprecipitates and cell lysates were then analyzed by immunoblotting separately using anti-HA and anti-Myc for Dvl2 and MEKK1, respectively.

Because Axin binds MEKK1-C and Dvl-2 is capable of binding Axin (Fig. 2), we asked if Dvl2 would affect the binding of MEKK1-C and Axin. In the presence of Axin, MEKK1-C was detected in the Dvl2 immunoprecipitate (Fig. 2), albeit in lower amounts. Reciprocal coimmunoprecipitation studies revealed a similar result (Fig. 2), indicating that the binding of Dvl2 to Axin did not affect the interaction of Axin with MEKK1-C.

View larger version (19K): [in this window] [in a new window]   Fig. 2.   Binding of Dvl2 and Axin does not affect the interaction between Axin and MEKK1-C. Cells were transfected with 1.5 µg of HA-Dvl2, 1.5 µg of Myc-Axin, and 1.5 µg of MEKK1-C in the various combinations as illustrated. Cell lysates were immunoprecipitated (IP) with anti-HA for Dvl2, anti-Myc for Axin, anti-MEKK1 for MEKK1-C, or control IgG. The immunoprecipitates and cell lysates were then analyzed by immunoblotting separately using anti-HA, anti-Myc, and anti-MEKK1 for Dvl2, Axin, and MEKK1-C, respectively.

Dvl2-DIX and Dvl2-DEP Proteins Deficient for JNK Activation Inhibit Axin-activated JNK Activity by Disrupting Axin Dimerization-- Dvl1, a Dishevelled family member, has been shown to interact with Axin, and the interaction is thought to be via their DIX domains, which are also capable of mediating oligomerization to form homo-oligomer (24). We investigated if there was cross-talk between Axin- and Dvl2-activated JNK. First we asked whether oligomerization of Dvl2 was required for JNK activation. Dishevelled is known to possess multiple domains: DIX, PDZ, and DEP (3, 4, 15). We generated a series of deletion mutants of HA-tagged Dvl2 and assayed for their abilities to activate JNK. As shown in Fig. 3B, the DEP domain, but not the N-terminal DIX and PDZ domains, was sufficient for the JNK activating activity of Dvl2, similar to studies performed on Dvl1 (25, 26). We asked whether the DEP domain played a role in dimerization of wild-type Dvl2. We found that Dvl2-DEP did not complex with wild-type Dvl2 even though Dvl2 was capable of self-interaction (Fig. 3A). These results suggest that oligomerization is not a requisite for Dvl2 to activate JNK.

View larger version (22K): [in this window] [in a new window]   Fig. 3.   Oligomerization is not needed for Dvl2 activation of JNK. A, self-association of Dvl2 proteins through the N terminus. Cells were transfected with 2 µg of Myc-Dvl2 together with 2 µg of either HA-Dvl2 or HA-Dvl2-DEP. Cell lysates were immunoprecipitated (IP) with anti-Myc, anti-HA, or control IgG. The immunoprecipitates and cell lysates were then analyzed by immunoblotting separately using anti-Myc and anti-HA for the Dvl2 proteins. B, structural requirements of Dvl2 for JNK activation. The schematic representation indicates the Dvl2 mutants used in transient transfection of 293T cells for immunokinase assays. The DIX, PDZ, and DEP domains are indicated, and dotted lines represent deletions. Cells were transfected with 1 µg of each HA-tagged Dvl2 construct plus 1 µg of FLAG-JNK1. Immunokinase assays were performed and are presented as described in the legend to Fig. 1. The extent of JNK activation are summarized as "+" for high activities, and "" for low activities.

Because Dvl2-DIX and Dvl2-DEP exhibited diminished JNK activation activity compared with wild-type Dvl2 (Fig. 3B), we cotransfected 293T cells with Axin and either of these Dvl2 mutants and asked if JNK activation by Axin would be affected. Overexpression of Axin alone robustly activated JNK (~9-fold) as seen previously (22), and this activity was increased to ~12-fold in the presence of wild-type Dvl2 and Dvl2-DEP. However, coexpression with either Dvl2-DIX or Dvl2-DEP significantly diminished the Axin-induced JNK activity in a dose-dependent manner (Fig. 4A), suggesting that Dvl2 mutants deleted for the DEP domain can regulate Axin activation of JNK, in which case they may bind Axin. To test this association, we performed immunoprecipitation assays using proteins tagged with different epitopes. Western blot analysis revealed that Myc-Axin coprecipitated with HA-Dvl2-DEP but not HA-Dvl2-DEP (Fig. 4C). Conversely, only HA-Dvl2-DEP coprecipitated with Myc-Axin. We noted that the complex formation between Axin and Dvl2-DEP reduced the homodimer formation between Axin itself (Fig. 4B). The association between Myc-Axin and HA-Dvl2-DIX was also detected in similar immunoprecipitation assays, albeit with lower affinity (data not shown). HA-Dvl2-DEP was capable of interacting with Axin at the C terminus (Myc-Axin-CT), which includes the dimerization domain, and removal of this C-terminal domain from Axin (Myc-Axin-C) impaired its ability to associate with Dvl2 (Fig. 4D). Taken together, these results suggest that the N terminus of Dvl2, which includes DIX and PDZ domains, can complex with the C-terminal region of Axin and regulate Axin-mediated JNK activity by disrupting the homo-oligomerization of Axin, which is prerequisite for JNK activation.

View larger version (37K): [in this window] [in a new window]   Fig. 4.   Axin activation of JNK is inhibited by Dvl2. A, Dvl2-DIX or Dvl2-DEP inhibits Axin activation of JNK, and inhibition is in a dose-dependent manner. Cells were transfected with 1 µg of FLAG-JNK1, plus 1 µg of Myc-Dvl2-DIX or Myc-Dvl2-DEP in the presence of 1 µg of HA-Axin. Immunokinase assays were performed and are presented as described in the legend to Fig. 1. For dose-dependent studies, cells were transiently transfected with 1 µg of HA-Axin and 1 µg of FLAG-JNK1 together with increasing amounts of Myc-Dvl2-DEP as indicated. Total cell lysates were probed with anti-HA and anti-Myc for the expression of Axin and Dvl2-DEP, respectively. Immunokinase assays were performed and are presented as described in the legend to Fig. 1. B, heterodimerization of Dvl2-DEP and Axin reduces Axin self-association. Cells were transfected with 1 µg each of FLAG-Axin and Myc-Axin in the absence or presence of HA-Dvl2-DEP at 1 or 2 µg. Cell lysates were immunoprecipitated (IP) with anti-HA, anti-FLAG, anti-Myc, or control IgG. The immunoprecipitates and cell lysates were then analyzed by immunoblotting separately using anti-HA for Dvl2-DEP and anti-Myc and anti-FLAG for the Axin proteins. C, Dvl2-DEP but not Dvl2-DEP forms a complex with wild-type Axin. Cells were transfected with 2 µg of Myc-Axin together with 2 µg of either HA-Dvl2-DEP or HA-Dvl2-DEP. Cell lysates were immunoprecipitated (IP) with anti-Myc, anti-HA, or control IgG. The immunoprecipitates and cell lysates were then analyzed by immunoblotting separately using anti-Myc and anti-HA for Axin and the Dvl2 proteins, respectively. D, Dvl2-DEP binds to the C terminus of Axin. Cells were transfected with 2 µg of HA-Dvl2-DEP together with 2 µg of either Myc-Axin-C or Myc-Axin-CT. Cell lysates were immunoprecipitated (IP) with anti-HA, anti-Myc, or control IgG. The immunoprecipitates and cell lysates were then analyzed by immunoblotting separately using anti-HA and anti-Myc for Dvl2-DEP and the Axin proteins, respectively.

Axin-MID, Axin-CT, and Axin-C Proteins Deficient for JNK Activation Do Not Interfere with Dishevelled-activated JNK Activity-- We have previously shown that mutant Axin proteins without the MID domain (Axin-MID), the N terminus (Axin-CT), or the C terminus including the DIX domain (Axin-C) are deficient for JNK activation (22). We next examined whether Axin could regulate Dvl2-induced JNK activity. Cells were transfected with Dvl2 alone or together with each of these mutant Axin proteins and assayed for their JNK kinase activities. As shown in Fig. 5A, coexpression with either Myc-Axin-MID or Myc-Axin-CT did not alter the level of JNK activated by Dvl2, despite their abilities to form complex with HA-Dvl2 (Fig. 5B). Myc-Axin-C, which also did not affect Dvl2 activation of JNK (Fig. 5A), did not bind Dvl2 (Fig. 5B). We obtained similar results when the same experiments were carried out with Dvl1 (Fig. 5A). Taken together, these data suggest that the Dishevelled-mediated JNK pathway is not regulated by Axin, and homodimerization is not requisite for Dishevelled activation of JNK.

View larger version (35K): [in this window] [in a new window]   Fig. 5.   Dvl2 activation of JNK is not affected by Axin. A, Axin-MID, Axin-C, or Axin-CT does not abolish Dvl1- or Dvl2-activated JNK activity. Cells were transfected with 1 µg of FLAG-JNK1, plus 2 µg of Myc-Axin-MID, Myc-Axin-C, or Myc-Axin-CT, in the presence of 1 µg of HA-Dvl1 or HA-Dvl2. Immunokinase assays were performed and are presented as described in the legend to Fig. 1. The expression of Axin proteins and Dvl proteins was detected by immunoblotting separately using anti-Myc and anti-HA, respectively. The schematic representation indicates the Axin mutants used. The binding sites for APC, GSK-3, -catenin, MID, and DIX domains are indicated, and dotted lines represent deletions. B, wild-type Dvl2 forms a complex with wild-type Axin, Axin-MID, and Axin-CT, but not Axin-C. Cells were transfected with 2 µg of Myc-Axin, Myc-Axin-MID, Myc-Axin-CT, or Myc-Axin-C in the presence of 1 µg of HA-Dvl2. Cell lysates were immunoprecipitated (IP) with anti-Myc, anti-HA, or control IgG. The immunoprecipitates and cell lysates were then analyzed by immunoblotting separately using anti-HA and anti-Myc for Dvl2 and the Axin proteins, respectively.

	DISCUSSION

TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES

It is most intriguing that Axin and Dishevelled, two critical factors that function as negative and positive regulators, respectively, in the same Wnt signaling pathway can activate a common kinase, JNK. The present study has examined if they activate JNK independently or cooperatively. We show that, whereas MEKK1 plays a critical role in JNK activation by Axin, it is not involved in Dvl2 activation of JNK, indicating that Axin and Dvl2 activate JNK through different mechanisms. Moreover, whereas Axin requires self-dimerization to activate JNK, Dvl2 does not. Heterodimerization between Axin and Dvl2 appears not to affect the ability of Dvl2 to activate JNK, yet it abolishes Axin activation of JNK.

Axin and Dishevelled proteins possess the conserved DIX domain, whose structural and functional importance has been revealed by several recent studies. Both a yeast two-hybrid interaction screen and in vitro binding studies demonstrate that Axin can bind itself through the DIX domain at the C terminus (14, 22-24, 27). Similarly, the N-terminal DIX domain of Dishevelled is necessary for self-interaction or the formation of heterodimers either among different Dishevelled family members or between Axin and Dishevelled proteins (24, 28). These biochemical interactions are supported by distribution studies in Xenopus embryos that show colocalization of Dishevelled and Axin within bright vesicular structures in the cytoplasm (8, 29). However, the significance of such homo- and heterodimer formation in the functions of Axin and Dishevelled remains to be clarified. Whereas it is known in Xenopus that removal of the DIX domain of Dishevelled results in total loss of the axis-inducing activity of Dishevelled (30), removal of the DIX domain of Axin does not affect its ability to ventralize frog embryos (8). We have recently shown Axin also has a functional role in activating the JNK signaling pathway and attributed the homo-oligomerization of wild-type Axin to be critical for JNK activation (22). Our results here clearly show that Dvl2-DEP forms a heterodimer with wild-type Axin, thereby abolishing Axin-mediated JNK activation. This suggests the formation of Axin homo- and heterodimers may provide a mode of regulation for Axin activation of JNK in that homodimers would favor JNK activation, whereas heterodimers would suppress JNK activation (Fig. 6).

View larger version (15K): [in this window] [in a new window]   Fig. 6.   Schematic model showing different dimeric combinations of Axin and Dishevelled determine their ability to activate JNK. Domains, MID in Axin, DEP in Dishevelled and their conserved DIX region, which are critical for JNK activation, are highlighted. Monomeric Axin is capable of binding to MEKK1, yet it cannot activate JNK. MEKK1-bound homodimerized Axin can activate JNK. In contrast to Axin, Dishevelled can activate JNK either as a monomer or dimer. Axin/Dishevelled heterodimers can activate JNK through Dishevelled but not through Axin. How cells achieve the balance between homodimerization and heterodimerization of Axin and Dishevelled remains unclear.

On the other hand, Dvl2 activation of JNK appears to be independent of the formation of homodimers/heterodimers, based on the observations (i) Dvl2-DEP, which lacks the ability to complex with wild-type Dvl2, still retains the capacity to activate JNK; and (ii) Axin mutants, which lack the MID domain or possess only the C terminus and are deficient for JNK activation, do not affect Dvl2 activation of JNK even though they are fully capable of complexing with Dvl2. Thus Dvl2 oligomerization may not be critical for activating JNK, in contrast to the strict requirement of Axin oligomerization for JNK activation. This accrues future studies to address how Axin and Dishevelled attain balances between homodimerization and heterodimerization. One intriguing possibility is that this balance may be regulated by Wnt signal. Axin is thought to be dephosphorylated and destabilized upon activation of the Wnt pathway (31). It is likely that the lowered abundance of Axin may favor its heterodimerization with Dishevelled, thereby deactivating Axin-JNK. It is equally possible that other factor(s) may be recruited to fine tune Axin function. In particular, with the advent of casein kinase as one of the major players in the Wnt pathway (32, 33), the regulatory signal may arise from factors other than the Wnt ligands.

The functional significance of the preferential inhibition of Axin-JNK by Dvl is not immediately clear. In our study, overexpression of Axin alone is likely to mimic a situation whereby Axin is in high abundance over Dishevelled when Wnt signals are absent, favoring the homodimerization of Axin. Coexpression of Axin with Dishevelled may represent a scenario in which Dishevelled delivers Wnt signals through interaction with the Axin-GSK-3 complex. Although this process is not entirely clear, recent work indicates Dvl1-Axin binding is necessary for the ability of Dvl1 and Axin to regulate the stability of -catenin (24), suggesting that the activated Wnt cascade favors the heterodimerization of Axin and Dishevelled. Activation of JNK is mediated via many signaling cascades and has been implicated in numerous cellular physiological processes, including morphogenesis, cell proliferation, and survival or cell death (34-37). Dishevelled activation of JNK in Drosophila plays a critical role in planar polarity signaling, in which cells determine their orientation in the plane of the epithelium and reorganize their cytoskeletons in a polarized array (15, 20, 25). Our finding that JNK activation by Dishevelled cannot be regulated by Axin suggests that planar polarity is separate from Axin function. However, it is unclear what the functional role of JNK activation of Axin is. The ubiquitous expression of Axin in almost all tissues from early embryonic development through to adult stage raises the possibility that Axin has a general role in regulating cell signaling, in addition to its well established role in embryonic axis formation. Our preliminary data suggest JNK activation by Axin may lead to apoptotic cell death.³ Work by Adachi-Yamada et al. (38) indicates that distortion of positional information in Drosophila during normal wing morphogenesis leads to JNK-dependent apoptosis of aberrant wing cells. It is possible that apoptosis caused by Axin may arise in those cells under conditions where the Axin to Dishevelled ratio is abnormally high. Dishevelled may be predicted to provide a means of controlling this Axin-JNK function, and the regulation is unique in that Dishevelled has the capacity to attenuate Axin-JNK, whereas Axin is unable to regulate Dvl-JNK.

In conclusion, our biochemical data strongly indicate that dimerization choices determine the ability of Axin and Dishevelled to activate JNK. The dimerization combination is likely to be determined by some switch mechanism that mediates which of the two should activate JNK under a given physiological situation and that commands cells to respond to various environmental cues.

	ACKNOWLEDGEMENTS

We thank Drs. M. Karin and A. Kikuchi for the various plasmids. We also thank Dr. Catherine Pallen for critical reading of the manuscript, Boon-Seng Soh and Wenjie Qiu for technical assistance, and Lai-Ping Yaw and Alex Tan for preparation of the manuscript.

	FOOTNOTES

^* This work was funded by the National Science and Technology Board of Singapore (to S.-C.L.) and by National Institutes of Health Grants GM51417 and AI41637 (to J. H.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

These authors contributed equally to this work.

^¶ To whom correspondence should be addressed. Tel.: 65-779-4560; Fax: 65-779-1117; E-mail: mcblinsc@imcb.nus.edu.sg.

Published, JBC Papers in Press, May 26, 2000, DOI 10.1074/jbc.M002491200

² Y. Zhang, S. Y. Neo, and S.-C. Lin, unpublished results.

³ S. Y. Neo, Y. Zhang, L. P. Yaw, P. Li, and S.-C. Lin, submitted for publication.

	ABBREVIATIONS

The abbreviations used are: APC, adenomatous polyposis coli; GSK-3, glycogen synthase kinase-3; DIX, Dishevelled homologous domain; PDZ, PSD-95/Dlg/ZO-1; DEP, Dishevelled/egl-10/pleckstrin; JNK, c-Jun N-terminal kinase; MEKK, mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase; MID, MEKK1-interacting domain; Dvl, Dishevelled; HA, hemagglutinin; GST, glutathione S-transferase; SAPK, stress-activated protein kinase.

	REFERENCES

TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				Z. Lu, W. Liu, H. Huang, Y. He, Y. Han, Y. Rui, Y. Wang, Q. Li, K. Ruan, Z. Ye, et al. Protein Encoded by the AxinFu Allele Effectively Down-regulates Wnt Signaling but Exerts a Dominant Negative Effect on c-Jun N-terminal Kinase Signaling J. Biol. Chem., May 9, 2008; 283(19): 13132 - 13139. [Abstract] [Full Text] [PDF]

				M. J. Smalley, N. Signoret, D. Robertson, A. Tilley, A. Hann, K. Ewan, Y. Ding, H. Paterson, and T. C. Dale Dishevelled (Dvl-2) activates canonical Wnt signalling in the absence of cytoplasmic puncta J. Cell Sci., November 15, 2005; 118(22): 5279 - 5289. [Abstract] [Full Text] [PDF]

				S Salahshor and J R Woodgett The links between axin and carcinogenesis J. Clin. Pathol., March 1, 2005; 58(3): 225 - 236. [Abstract] [Full Text] [PDF]

				W. Luo, H. Zou, L. Jin, S. Lin, Q. Li, Z. Ye, H. Rui, and S.-C. Lin Axin Contains Three Separable Domains That Confer Intramolecular, Homodimeric, and Heterodimeric Interactions Involved in Distinct Functions J. Biol. Chem., February 11, 2005; 280(6): 5054 - 5060. [Abstract] [Full Text] [PDF]

				C. K. Wong, W. Luo, Y. Deng, H. Zou, Z. Ye, and S.-C. Lin The DIX Domain Protein Coiled-coil-DIX1 Inhibits c-Jun N-terminal Kinase Activation by Axin and Dishevelled through Distinct Mechanisms J. Biol. Chem., September 17, 2004; 279(38): 39366 - 39373. [Abstract] [Full Text] [PDF]

				W. Luo, W. W. Ng, L.-H. Jin, Z. Ye, J. Han, and S.-C. Lin Axin Utilizes Distinct Regions for Competitive MEKK1 and MEKK4 Binding and JNK Activation J. Biol. Chem., September 26, 2003; 278(39): 37451 - 37458. [Abstract] [Full Text] [PDF]

				L. C. Sheldahl, D. C. Slusarski, P. Pandur, J. R. Miller, M. Kuhl, and R. T. Moon Dishevelled activates Ca2+ flux, PKC, and CamKII in vertebrate embryos J. Cell Biol., May 26, 2003; 161(4): 769 - 777. [Abstract] [Full Text] [PDF]

				J. W. Kim, J. E. Lee, M. J. Kim, E.-G. Cho, S.-G. Cho, and E.-J. Choi Glycogen Synthase Kinase 3beta Is a Natural Activator of Mitogen-activated Protein Kinase/Extracellular Signal-regulated Kinase Kinase Kinase 1 (MEKK1) J. Biol. Chem., April 11, 2003; 278(16): 13995 - 14001. [Abstract] [Full Text] [PDF]

				H.-L. Rui, E. Fan, H.-M. Zhou, Z. Xu, Y. Zhang, and S.-C. Lin SUMO-1 Modification of the C-terminal KVEKVD of Axin Is Required for JNK Activation but Has No Effect on Wnt Signaling J. Biol. Chem., November 1, 2002; 277(45): 42981 - 42986. [Abstract] [Full Text] [PDF]

				S. Kusano and N. Raab-Traub I-mfa Domain Proteins Interact with Axin and Affect Its Regulation of the Wnt and c-Jun N-Terminal Kinase Signaling Pathways Mol. Cell. Biol., September 15, 2002; 22(18): 6393 - 6405. [Abstract] [Full Text] [PDF]

				J. Y. Leung, F. T. Kolligs, R. Wu, Y. Zhai, R. Kuick, S. Hanash, K. R. Cho, and E. R. Fearon Activation of AXIN2 Expression by beta -Catenin-T Cell Factor. A FEEDBACK REPRESSOR PATHWAY REGULATING Wnt SIGNALING J. Biol. Chem., June 7, 2002; 277(24): 21657 - 21665. [Abstract] [Full Text] [PDF]

				Y. Zhang, W.-J. Qiu, S. C. Chan, J. Han, X. He, and S.-C. Lin Casein Kinase I and Casein Kinase II Differentially Regulate Axin Function in Wnt and JNK Pathways J. Biol. Chem., May 10, 2002; 277(20): 17706 - 17712. [Abstract] [Full Text] [PDF]

				Y. Zhang, W.-J. Qiu, D.-X. Liu, S. Y. Neo, X. He, and S.-C. Lin Differential Molecular Assemblies Underlie the Dual Function of Axin in Modulating the Wnt and JNK Pathways J. Biol. Chem., August 17, 2001; 276(34): 32152 - 32159. [Abstract] [Full Text] [PDF]

This Article Abstract Full Text (PDF) All Versions of this Article: 275/32/25008    most recent M002491200v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zhang, Y. Articles by Lin, S.-C. Search for Related Content PubMed PubMed Citation